The characterisation of molecular abnormalities in patients with lung cancers has led to the development of a number of targeted therapies, mainly based on mutations in the EGFR, ALK or KRAS genes
Authors
Others publications
Iron overload
Iron overload and porphyria cutanea tarda
Immunology
2018 Colloquium: A word from the President
Neurodegenerative diseases
Delayed lithium treatment positively regulates neurogenesis after radiationinduced damage to the developing brain
Immunology
Role of the gut microbiota in psychiatric diseases